Pfizer and BioNTech coronavirus vaccine is safe and effective for kids in 5 to 11-year-olds, as per the data shown by both companies on Monday.
The trial was run on 2,268 kids in 5 to 11-year-olds and used a lesser dose compared to the amount given to people ages 12 and older, for the safety of younger children.
The companies said that the vaccine was safe, well-tolerated, and indicated positive antibody responses in the participants 5 to 11 years of age.
Pfizer and BioNTech are planning to file for an emergency approval with the U.S. Food and Drug Administration. COVID-19 cases in young children are rising due to the Delta variant, which has shocked the health officials in the United States.
Both the companies said that they will submit a request to the European Medicines Agency and other regulators for emergency approval in the United States.
Earlier in August, the FDA has approved the Pfizer vaccine, for people ages 16 and older. Now, it is approved for emergency use in children ages 12 to 15
Pfizer and BioNTech also say that results from the two other ongoing trials are anticipated as soon as later this year. They are studying the vaccination on children ages 2 to 5 and one of the children 6 months to 2 years old.
Pfizer also received the emergency use authorization for the third dose of vaccine to those 12 years of age and older from the FDA
Few other companies like Johnson & Johnson and Moderna, are studying their coronavirus vaccines in kids.